• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Hyperion Therapeutics Inc

+ Add to Watchlist

HPTX:US

25.8600 USD 0.7000 2.78%

As of 20:10:00 ET on 08/29/2014.

Snapshot for Hyperion Therapeutics Inc (HPTX)

Open: 25.1700 Day's Range: 24.9800 - 25.9000 Volume: 55,951
Previous Close: 25.1600 52wk Range: 18.9740 - 32.9800 1-Yr Rtn: +6.07%

Stock Chart for HPTX

No chart data available.
  • HPTX:US 25.8600
  • 1D
  • 1M
  • 1Y
25.1600
Interactive HPTX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HPTX

Current P/E Ratio (ttm) 27.6691
Estimated P/E(12/2014) 55.2564
Relative P/E vs. SPX 1.5420
Earnings Per Share (USD) (ttm) 0.9346
Est. EPS (USD) (12/2014) 0.4680
Est. PEG Ratio -
Market Cap (M USD) 532.66
Shares Outstanding (M) 20.60
30 Day Average Volume 113,721
Price/Book (mrq) 3.5330
Price/Sale (ttm) 5.7646
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HPTX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HPTX

Hyperion Therapeutics Inc. operates as a biopharmaceutical company. The Company develops therapeutics to treat disorders in the areas of orphan diseases and hepatology. Hyperion Therapeutics offers its services throughout the United States.

James I Healy "Jim"ChairmanDonald J SantelChief Executive Officer
Jeffrey S FarrowChief Financial OfficerBruce F ScharschmidtSenior VP/Chief Medical Ofcr
More Company Profile & Key Executives for HPTX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil